PELLEGRINI, CAROLINA Statistiche
PELLEGRINI, CAROLINA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
Development of an adipocyte differentiation protocol using 3T3-L1 cells for the investigation of the browning process: identification of the PPAR-γ agonist rosiglitazone as a browning reference drug
2025-01-01 Flori, L.; Galgani, G.; Bray, G.; Ippolito, C.; Segnani, C.; Pellegrini, C.; Citi, V.; Bernardini, N.; Martelli, A.; Calderone, V.
Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity
2025-01-01 D'Antongiovanni, V.; Fornai, M.; Colucci, R.; Nericcio, A.; Benvenuti, L.; Disalvo, C.; Segnani, C.; Pierucci, C.; Ippolito, C.; Nemeth, Z. H.; Hasko, G.; Bernardini, N.; Antonioli, L.; Pellegrini, C.
How leaky is the gut in Parkinson’s disease?
2025-01-01 Derkinderen, Pascal; Cossais, François; Kulcsárová, Kristína; Škorvánek, Matej; Sellier-Montaigne, Loïc; Coron, Emmanuel; Leclair-Visonneau, Laurène; Cerri, Silvia; Pellegrini, Carolina; Rolli-Derkinderen, Malvyne
Editorial: Reviews in neuropharmacology 2023: microbiota gut-brain axis, therapeutic insights for neurodegenerative diseases
2024-01-01 Sivamaruthi, Bhagavathi Sundaram; Suganthy, Natarajan; Pellegrini, Carolina
Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis
2024-01-01 D'Antongiovanni, V.; Pellegrini, C.; Antonioli, L.; Ippolito, C.; Segnani, C.; Benvenuti, L.; D'Amati, A.; Errede, M.; Virgintino, D.; Fornai, M.; Bernardini, N.
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study
2024-01-01 Lucarini, E.; Benvenuti, L.; Di Salvo, C.; D'Antongiovanni, V.; Pellegrini, C.; Valdiserra, G.; Ciampi, C.; Antonioli, L.; Lambiase, C.; Cancelli, L.; Grosso, A.; Di Cesare Mannelli, L.; Bellini, M.; Ghelardini, C.; Fornai, M.
Gastrointestinal dysmotility in rodent models of Parkinson’s disease
2024-01-01 Pellegrini, C.; Travagli, R. A.
Gut-directed therapy in Parkinson’s disease
2024-01-01 Benvenuti, Laura; Di Salvo, Clelia; Bellini, Gabriele; Seguella, Luisa; Rettura, Francesco; Esposito, Giuseppe; Antonioli, Luca; Ceravolo, Roberto; Bernardini, Nunzia; Pellegrini, Carolina; Fornai, Matteo
Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis
2024-01-01 Di Salvo, C.; D'Antongiovanni, V.; Benvenuti, L.; D'Amati, A.; Ippolito, C.; Segnani, C.; Pierucci, C.; Bellini, G.; Annese, T.; Virgintino, D.; Colucci, R.; Antonioli, L.; Fornai, M.; Errede, M.; Bernardini, N.; Pellegrini, C.
Prokineticin-2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients
2024-01-01 Bellini, G.; Rettura, F.; Palermo, G.; Ippolito, C.; Segnani, C.; Pierucci, C.; Fontanelli, L.; Frosini, D.; Nardini, V.; Lambiase, C.; Bernardini, N.; Pellegrini, C.; Ceravolo, R.
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis
2024-01-01 Di Salvo, C.; D'Antongiovanni, V.; Benvenuti, L.; Fornai, M.; Valdiserra, G.; Natale, G.; Ryskalin, L.; Lucarini, E.; Mannelli, L. D. C.; Ghelardini, C.; Colucci, R.; Hasko, G.; Pellegrini, C.; Antonioli, L.
α-Synuclein in Parkinson's Disease: From Bench to Bedside
2024-01-01 Bellini, Gabriele; D'Antongiovanni, Vanessa; Palermo, Giovanni; Antonioli, Luca; Fornai, Matteo; Ceravolo, Roberto; Bernardini, Nunzia; Derkinderen, Pascal; Pellegrini, Carolina
Adenosine signaling as target in cardiovascular pharmacology
2023-01-01 Antonioli, Luca; Fornai, Matteo; Pellegrini, Carolina; Pacher, Pál; Haskó, György
Are LRRK2 mysteries lurking in the gut?
2023-01-01 de Guilhem de Lataillade, Adrien; Pellegrini, Carolina; Neunlist, Michel; Rolli-Derkinderen, Malvyne; Derkinderen, Pascal
Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology (npj Parkinson's Disease, (2022), 8, 1, (9), 10.1038/s41531-021-00263-x)
2023-01-01 Pellegrini, C.; D'Antongiovanni, V.; Miraglia, F.; Rota, L.; Benvenuti, L.; Di Salvo, C.; Testa, G.; Capsoni, S.; Carta, G.; Antonioli, L.; Cattaneo, A.; Blandizzi, C.; Colla, E.; Fornai, M.
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity
2023-01-01 D'Antongiovanni, V.; Fornai, M.; Benvenuti, L.; Di Salvo, C.; Pellegrini, C.; Cappelli, F.; Masi, S.; Antonioli, L.
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability
2023-01-01 Benvenuti, L.; D'Antongiovanni, V.; Pellegrini, C.; Fornai, M.; Bernardini, N.; Ippolito, C.; Segnani, C.; Di Salvo, C.; Colucci, R.; Martelli, A.; Flori, L.; Calderone, V.; Carta, G.; Ghelardi, E.; Calvigioni, M.; Panattoni, A.; Coppolecchia, R.; Arini, A.; Antonioli, L.
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease
2023-01-01 Bellini, G.; Benvenuti, L.; Ippolito, C.; Frosini, D.; Segnani, C.; Rettura, F.; Pancetti, A.; Bertani, L.; D'Antongiovanni, V.; Palermo, G.; Del Prete, E.; Antonioli, L.; Nardini, V.; Morganti, R.; Pellegrini, C.; Bernardini, N.; Ceravolo, R.; Fornai, M.; Bellini, M.
LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines
2023-01-01 de Guilhem de Lataillade, Adrien; Caillaud, Martial; Oullier, Thibauld; Naveilhan, Philippe; Pellegrini, Carolina; Tolosa, Eduardo; Neunlist, Michel; Rolli-Derkinderen, Malvyne; Gelpi, Ellen; Derkinderen, Pascal
Pathological Remodeling of the Gut Barrier as a Prodromal Event of High-Fat Diet-Induced Obesity
2023-01-01 D'Antongiovanni, V.; Segnani, C.; Ippolito, C.; Antonioli, L.; Colucci, R.; Fornai, M.; Bernardini, N.; Pellegrini, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Development of an adipocyte differentiation protocol using 3T3-L1 cells for the investigation of the browning process: identification of the PPAR-γ agonist rosiglitazone as a browning reference drug | 1-gen-2025 | Flori, L.; Galgani, G.; Bray, G.; Ippolito, C.; Segnani, C.; Pellegrini, C.; Citi, V.; Bernardini, N.; Martelli, A.; Calderone, V. | |
| Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity | 1-gen-2025 | D'Antongiovanni, V.; Fornai, M.; Colucci, R.; Nericcio, A.; Benvenuti, L.; Disalvo, C.; Segnani, C.; Pierucci, C.; Ippolito, C.; Nemeth, Z. H.; Hasko, G.; Bernardini, N.; Antonioli, L.; Pellegrini, C. | |
| How leaky is the gut in Parkinson’s disease? | 1-gen-2025 | Derkinderen, Pascal; Cossais, François; Kulcsárová, Kristína; Škorvánek, Matej; Sellier-Montaigne, Loïc; Coron, Emmanuel; Leclair-Visonneau, Laurène; Cerri, Silvia; Pellegrini, Carolina; Rolli-Derkinderen, Malvyne | |
| Editorial: Reviews in neuropharmacology 2023: microbiota gut-brain axis, therapeutic insights for neurodegenerative diseases | 1-gen-2024 | Sivamaruthi, Bhagavathi Sundaram; Suganthy, Natarajan; Pellegrini, Carolina | |
| Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis | 1-gen-2024 | D'Antongiovanni, V.; Pellegrini, C.; Antonioli, L.; Ippolito, C.; Segnani, C.; Benvenuti, L.; D'Amati, A.; Errede, M.; Virgintino, D.; Fornai, M.; Bernardini, N. | |
| Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study | 1-gen-2024 | Lucarini, E.; Benvenuti, L.; Di Salvo, C.; D'Antongiovanni, V.; Pellegrini, C.; Valdiserra, G.; Ciampi, C.; Antonioli, L.; Lambiase, C.; Cancelli, L.; Grosso, A.; Di Cesare Mannelli, L.; Bellini, M.; Ghelardini, C.; Fornai, M. | |
| Gastrointestinal dysmotility in rodent models of Parkinson’s disease | 1-gen-2024 | Pellegrini, C.; Travagli, R. A. | |
| Gut-directed therapy in Parkinson’s disease | 1-gen-2024 | Benvenuti, Laura; Di Salvo, Clelia; Bellini, Gabriele; Seguella, Luisa; Rettura, Francesco; Esposito, Giuseppe; Antonioli, Luca; Ceravolo, Roberto; Bernardini, Nunzia; Pellegrini, Carolina; Fornai, Matteo | |
| Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis | 1-gen-2024 | Di Salvo, C.; D'Antongiovanni, V.; Benvenuti, L.; D'Amati, A.; Ippolito, C.; Segnani, C.; Pierucci, C.; Bellini, G.; Annese, T.; Virgintino, D.; Colucci, R.; Antonioli, L.; Fornai, M.; Errede, M.; Bernardini, N.; Pellegrini, C. | |
| Prokineticin-2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients | 1-gen-2024 | Bellini, G.; Rettura, F.; Palermo, G.; Ippolito, C.; Segnani, C.; Pierucci, C.; Fontanelli, L.; Frosini, D.; Nardini, V.; Lambiase, C.; Bernardini, N.; Pellegrini, C.; Ceravolo, R. | |
| The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis | 1-gen-2024 | Di Salvo, C.; D'Antongiovanni, V.; Benvenuti, L.; Fornai, M.; Valdiserra, G.; Natale, G.; Ryskalin, L.; Lucarini, E.; Mannelli, L. D. C.; Ghelardini, C.; Colucci, R.; Hasko, G.; Pellegrini, C.; Antonioli, L. | |
| α-Synuclein in Parkinson's Disease: From Bench to Bedside | 1-gen-2024 | Bellini, Gabriele; D'Antongiovanni, Vanessa; Palermo, Giovanni; Antonioli, Luca; Fornai, Matteo; Ceravolo, Roberto; Bernardini, Nunzia; Derkinderen, Pascal; Pellegrini, Carolina | |
| Adenosine signaling as target in cardiovascular pharmacology | 1-gen-2023 | Antonioli, Luca; Fornai, Matteo; Pellegrini, Carolina; Pacher, Pál; Haskó, György | |
| Are LRRK2 mysteries lurking in the gut? | 1-gen-2023 | de Guilhem de Lataillade, Adrien; Pellegrini, Carolina; Neunlist, Michel; Rolli-Derkinderen, Malvyne; Derkinderen, Pascal | |
| Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology (npj Parkinson's Disease, (2022), 8, 1, (9), 10.1038/s41531-021-00263-x) | 1-gen-2023 | Pellegrini, C.; D'Antongiovanni, V.; Miraglia, F.; Rota, L.; Benvenuti, L.; Di Salvo, C.; Testa, G.; Capsoni, S.; Carta, G.; Antonioli, L.; Cattaneo, A.; Blandizzi, C.; Colla, E.; Fornai, M. | |
| Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity | 1-gen-2023 | D'Antongiovanni, V.; Fornai, M.; Benvenuti, L.; Di Salvo, C.; Pellegrini, C.; Cappelli, F.; Masi, S.; Antonioli, L. | |
| Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability | 1-gen-2023 | Benvenuti, L.; D'Antongiovanni, V.; Pellegrini, C.; Fornai, M.; Bernardini, N.; Ippolito, C.; Segnani, C.; Di Salvo, C.; Colucci, R.; Martelli, A.; Flori, L.; Calderone, V.; Carta, G.; Ghelardi, E.; Calvigioni, M.; Panattoni, A.; Coppolecchia, R.; Arini, A.; Antonioli, L. | |
| Intestinal histomorphological and molecular alterations in patients with Parkinson's disease | 1-gen-2023 | Bellini, G.; Benvenuti, L.; Ippolito, C.; Frosini, D.; Segnani, C.; Rettura, F.; Pancetti, A.; Bertani, L.; D'Antongiovanni, V.; Palermo, G.; Del Prete, E.; Antonioli, L.; Nardini, V.; Morganti, R.; Pellegrini, C.; Bernardini, N.; Ceravolo, R.; Fornai, M.; Bellini, M. | |
| LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines | 1-gen-2023 | de Guilhem de Lataillade, Adrien; Caillaud, Martial; Oullier, Thibauld; Naveilhan, Philippe; Pellegrini, Carolina; Tolosa, Eduardo; Neunlist, Michel; Rolli-Derkinderen, Malvyne; Gelpi, Ellen; Derkinderen, Pascal | |
| Pathological Remodeling of the Gut Barrier as a Prodromal Event of High-Fat Diet-Induced Obesity | 1-gen-2023 | D'Antongiovanni, V.; Segnani, C.; Ippolito, C.; Antonioli, L.; Colucci, R.; Fornai, M.; Bernardini, N.; Pellegrini, C. |